Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#MarkupMadness
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
AAM All Access Podcast
- Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.
Learn More
Close
Breadcrumb
Home
Resources
Blog
Blog
Share
Blog
May 31, 2022
| Erica Klinger
Everything You Need to Know About Biosimilars – All in One Place
Blog
May 23, 2022
| Monét Stanford
AAM Calls for Federal Trade Commission to Investigate PBM Business Practices
Blog
May 2, 2022
| Monét Stanford
Generics Drive Savings Yet Patients Continue to Pay More
Blog
Apr 19, 2022
| Monét Stanford
As Health Care Spending in US Projected to Increase, Generics and Biosimilars Expected to Moderate Growth
Blog
Apr 19, 2022
| Monét Stanford
Challenges & Solutions for Prescription Drug Savings Identified by MedPAC
Blog
Apr 8, 2022
| Steven Selde
HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use
Blog
Mar 30, 2022
| Erica Klinger
KC is Enjoying Life— “a Pretty Good Deal” on Prescriptions
Blog
Mar 24, 2022
| Sara Skubikowski
The Savings Add Up for Patients
Blog
Mar 23, 2022
| Erica Klinger
Greg is Treating His Ulcerative Colitis, and Enjoying a Slice or Two
Blog
Mar 18, 2022
| Monét Stanford
Senate Finance Hearing Highlights Ways to Reduce Drug Prices without Harming Patients
Blog
Mar 15, 2022
| Erica Klinger
Eileen is Singing, Dancing and Taking Care of Herself with Biosimilars
Blog
Mar 7, 2022
| Joanne Duncan
Women’s History Month: Honoring Yesterday’s and Today’s Leaders
Load More
Advocacy
Issue Overview
#MarkupMadness
#Rx4StateSavings
GDUFA/BsUFA User Fees
Build Back Better
State Legislation
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Meet Our Board
Social Commitment
Generic Medicines
Biosimilars
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
All Access Podcast
2021 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action